Breaking News Instant updates and real-time market news.

CLNT

Cleantech Solutions

$4.16

-0.1217 (-2.84%)

, AHH

Armada Hoffler

$13.59

0.13 (0.97%)

17:45
06/12/17
06/12
17:45
06/12/17
17:45

On The Fly: After Hours Movers

HIGHER: Cleantech Solutions (CLNT), up 12.6% after the company entered into exclusive talks with ECrent Capital... Armada Hoffler (AHH), up 3.5% after it was named to the S&P SmallCap 600. DOWN AFTER EARNINGS: SAIC (SAIC), down 9.9%. ALSO LOWER: Acceleron (XLRN), down 5.1% after it said that it is discontinuing the development of dalantercept... Synaptics (SYNA), down 2.2% after it agreed to acquire Conexant for $300M in cash and 726,666 shares of common stock... First Industrial (FR), down 1.8% after it announced a 2.56M share common stock offering... Hi-Crush Partners (HCLP) and Emerge Energy (EMES), down a respective 1.6% and 1.5% after U.S. Silica (SLCA) said its board approve the construction of a new frac sand mine and plant in West Texas to serve the Permian Basin... Merck (MRK), down 1% after it halted enrollment on the KEYNOTE-183 and KEYNOTE-185 trials.

CLNT

Cleantech Solutions

$4.16

-0.1217 (-2.84%)

AHH

Armada Hoffler

$13.59

0.13 (0.97%)

SAIC

SAIC

$81.44

4.39 (5.70%)

XLRN

Acceleron

$28.23

-0.81 (-2.79%)

SYNA

Synaptics

$58.79

-0.87 (-1.46%)

FR

First Industrial Realty

$30.04

0.34 (1.14%)

HCLP

Hi-Crush Partners

$12.55

0.25 (2.03%)

EMES

Emerge Energy

$10.37

0.41 (4.12%)

SLCA

U.S. Silica

$36.31

-0.07 (-0.19%)

MRK

Merck

  • 12

    Jun

  • 14

    Jun

  • 20

    Jun

  • 20

    Jun

  • 22

    Jun

  • 26

    Jun

  • 22

    Sep

  • 13

    Jun

CLNT Cleantech Solutions
$4.16

-0.1217 (-2.84%)

AHH Armada Hoffler
$13.59

0.13 (0.97%)

05/19/17
RAJA
05/19/17
NO CHANGE
RAJA
Outperform
Armada Hoffler weakness a buying opportunity. at Raymond James
Raymond James said the pullback in Armada Hoffler shares provides an attractive buying opportunity ahead of accelerating external growth in 2018, which will offset what looks to be flattish growth in 2017.
10/14/16
DADA
10/14/16
INITIATION
Target $15
DADA
Buy
Armada Hoffler initiated with a Buy at DA Davidson
DA Davidson analyst James Lykins initiated Armada Hoffler with a Buy and a $15 price target
12/14/16
WDLK
12/14/16
DOWNGRADE
WDLK
Hold
Armada Hoffler downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Craig Kucera downgraded Armada Hoffler to Hold with a $14.50 price target.
SAIC SAIC
$81.44

4.39 (5.70%)

12/09/16
RHCO
12/09/16
NO CHANGE
RHCO
SAIC price target raIsed to $93 from $74 at SunTrust
SunTrust analyst Tobey Sommer raised the price target on SAIC after the company reported higher than expected Q3 EPS but slightly lower than expected revenue. The analyst says that the $14B in bids submitted by the company for contracts yet to be awarded "reflect a more profitable mix." As a result, Sommer expects the company's positive momentum to continue. The analyst keeps a Buy rating on the shares.
03/31/17
SBSH
03/31/17
NO CHANGE
Target $83
SBSH
Neutral
SAIC may modestly recover after yesterday's selloff, says Citi
Citi analyst Jonathan Raviv says he saw "nothing earth-shattering" in SAIC's sales miss, as it came down to 100-200 basis points "here or there." The analyst would not be surprised to see "some modest stock recovery" as investors are attracted by a greater than 7% free cash flow yield. Raviv lowered his price target for SAIC shares to $83 from $86 and keeps a Neutral rating on the name. He remains concerned with this year's AMCOM re-compete.
03/16/17
VERT
03/16/17
INITIATION
VERT
Hold
SAIC initiated with a Hold at Vertical Research
Vertical Research analyst Krishna Sinha started SAIC with a Hold rating.
02/16/17
GHSC
02/16/17
INITIATION
Target $93
GHSC
Buy
SAIC initiated with a Buy at Seaport Global
Seaport Global analyst Josh Sullivan started SAIC with a Buy rating and $93 price target.
XLRN Acceleron
$28.23

-0.81 (-2.79%)

04/18/17
FBCO
04/18/17
INITIATION
Target $46
FBCO
Outperform
Acceleron assumed with an Outperform at Credit Suisse
Target $46.
03/23/17
03/23/17
NO CHANGE

Outperform
Acceleron added to Alpha Generator List at FBR Capital
05/17/17
05/17/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CoreSite Realty (COR) initiated with a Market Perform at Wells Fargo. 2. Acceleron (XLRN) initiated with a Sell at Goldman Sachs. 3. Cardinal Health (CAH) initiated with a Hold at Jefferies. 4. Concho Resources (CXO) assumed with an Overweight at Piper Jaffray. 5. Triangle Capital (TCAP) initiated with a Buy at Wunderlich. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/17
GSCO
05/17/17
INITIATION
Target $20
GSCO
Sell
Acceleron initiated with a Sell at Goldman Sachs
Goldman analyst Terence Flynn initiated Acceleron with a Sell and a $20 price target saying Luspatercept is the key driver but most opportunities are already reflected in valuation. Flynn said Luspatercept Phase 3 data for two blood disorders isn't expected until mid-2018 and expects shares to be a relative underperformer given the lack of catalysts this year.
SYNA Synaptics
$58.79

-0.87 (-1.46%)

03/21/17
COWN
03/21/17
NO CHANGE
COWN
Synaptics shares defended at Cowen
04/07/17
NEED
04/07/17
UPGRADE
NEED
Buy
Synaptics upgraded to Buy from Hold at Needham
04/07/17
04/07/17
UPGRADE
Target $60

Buy
Synaptics upgraded to Buy at Needham
As previously reported, Needham analyst Rajvindra Gill upgraded Synaptics to Buy from Hold, with a $60 price target, saying his bearish thesis of lower gross margins and OLED market share loss has been played out and is now reflected in the stock. Despite the volatility in the business, Synaptics remains the dominant player in display market, possessing the engineering capability and scale to over time integrate touch, display and fingerprint on the display, and creating considerable barriers to entry, he contended.
03/30/17
CHLM
03/30/17
NO CHANGE
CHLM
Samsung S8 launch positive for STMicroelectronics, others, says Craig-Hallum
Craig-Hallum analyst Tony Stoss notes that Samsung (SSNLF) Galaxy S8's features were as he had expected, which is positive for STMicroelectronics (STM), Cypress Semiconductor (CY) and Integrated Device Synaptics (IDTI), and largely a non-impact for Synaptics (SYNA). The analyst says Samsung using USB-C for the port should be a benefit for Cypress as it is the likely supplier of USB-C controllers for the phone. Additionally, Samsung has enabled the S8 for wireless fast charging and showcased a fast charge wireless pad, which is likely an ASP increase from previous wireless charging solutions Integrated Device Synaptics was providing. The phone also features a fingerprint sensor on the back that is likely Synaptics, he notes, adding that this should be roughly in-line with previous ASP's of fingerprint sensors that the latter has provided to Samsung.
FR First Industrial Realty
$30.04

0.34 (1.14%)

01/11/17
BARD
01/11/17
DOWNGRADE
Target $28
BARD
Neutral
First Industrial Realty downgraded to Neutral at Baird
As previously reported, Baird analyst David Rodgers downgraded First Industrial Realty to Neutral from Outperform citing valuation. Rodgers lowered his price target to $28 from $29 on First Industrial Realty shares.
01/11/17
BARD
01/11/17
DOWNGRADE
BARD
Neutral
First Industrial Realty downgraded to Neutral from Outperform at Baird
HCLP Hi-Crush Partners
$12.55

0.25 (2.03%)

05/03/17
MZHO
05/03/17
INITIATION
Target $20
MZHO
Buy
Hi-Crush Partners initiated with a Buy at Mizuho
Mizuho analyst Brian Zarahn initiated Hi-Crush Partners with a Buy and a $20 price target citing the pullback in shares and robust sand demand growth.
05/25/17
EVER
05/25/17
INITIATION
EVER
Outperform
Hi-Crush Partners initiated with an Outperform at Evercore ISI
Evercore ISI analyst Samantha Hoh initiated Hi-Crush Partners with an Outperform and a $22 price target telling investors distributable cash flow is turning positive, earnings visibility is improving, and expects it resume paying an attractive dividend soon.
04/04/17
UBSW
04/04/17
UPGRADE
Target $23
UBSW
Buy
Hi-Crush Partners upgraded to Buy from Neutral at UBS
UBS analyst Shneur Gershuni upgraded Hi-Crush Partners to Buy saying the company has positioned itself to benefit from improving sand demand. The analyst also highlights the recent pullback in the shares. He raised his price target for Hi-Crush to $23 from $22.
03/27/17
GUGG
03/27/17
INITIATION
Target $31
GUGG
Buy
Hi-Crush Partners initiated with a Buy at Guggenheim
Guggenheim initiated Hi-Crush Partners initiated with a Buy and a $31 price target.
EMES Emerge Energy
$10.37

0.41 (4.12%)

05/25/17
EVER
05/25/17
INITIATION
EVER
In Line
Emerge Energy initiated with an In Line at Evercore ISI
Evercore ISI analyst Samantha Hoh initiated Emerge Energy with an In Line and a $15 price target saying there is some risk to its execution story.
09/29/16
WDLK
09/29/16
UPGRADE
Target $15
WDLK
Buy
Emerge Energy upgraded to Buy from Hold at Wunderlich
Wunderlich analyst Jason Wangler upgraded Emerge Energy Services LP to Buy and raised his price target for the shares to $15 from $12.
05/04/17
STFL
05/04/17
UPGRADE
Target $16
STFL
Buy
Emerge Energy upgraded to Buy from Hold at Stifel
Stifel upgraded Emerge Energy to Buy from Hold and raised its price target to $16 from $14 following the Q1 report. The analyst said Emerge reported positive Q1 adjusted EBITDA for the first time since Q4 2015 with higher volumes and margins that should continue through Q2 and the remainder of 2017.
01/20/17
GSCO
01/20/17
UPGRADE
GSCO
Buy
Emerge Energy upgraded to Buy from Neutral at Goldman
Goldman analyst Waqar Syed upgraded Emerge Energy to Buy and raised its price target to $20 from $11 given tightening sand supply. The analyst said the frac sand market is rapidly tightening as rig counts have increased off a May 2016 bottom. Syed said Emerge Energy's Wisconson based mines have sizeable available capacity to become the marginal supplier and believes the company should see a significant increase in its capacity utilization.
SLCA U.S. Silica
$36.31

-0.07 (-0.19%)

06/06/17
WOLF
06/06/17
DOWNGRADE
WOLF
Peer Perform
U.S. Silica downgraded to Peer Perform from Outperform at Wolfe Research
05/05/17
RHCO
05/05/17
NO CHANGE
RHCO
Oilfield services stocks oversold, says SunTrust
SunTrust analyst Ken Sill says that oil services stocks are nearing their September 2016 lows, even though the sector's fundamentals are much better now than then. He recommends buying Halliburton (HAL), Silica (SLCA), and RPC, Inc. (RES).
05/22/17
GSCO
05/22/17
DOWNGRADE
Target $45
GSCO
Sell
Helmerich & Payne downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Waqar Syed downgraded Helmerich & Payne (HP) to Sell saying the valuation and consensus estimates have downside risk as the U.S. land rig count flattens over the coming months. The analyst expects dayrates to peak around $20,000 per day, which he sees driving consensus estimates lower. Syed cut his price target for Helmerich to $45 from $63. He continues to recommend Halliburton (HAL), ProPetro Holding (PUMP) and U.S. Silica (SLCA) with Buy ratings.
05/25/17
EVER
05/25/17
INITIATION
EVER
Outperform
U.S. Silica initiated with an Outperform at Evercore ISI
Evercore ISI analyst Samantha Hoh initiated U.S. Silica with an Outperform and a $48 price target saying it commands a leading market share in both frac sand and industrial sand, and has the most developed last mile logistics solution. The analyst also said it has a strong balance sheet and visible growth.
MRK Merck

05/22/17
ADAM
05/22/17
NO CHANGE
Target $85
ADAM
Buy
CV events 'may kill' Amgen's romosozumab development, says Canaccord
Canaccord analyst John Newman said Amgen (AMGN) and partner UCB's report of a higher rate of cardiovascular Serious Adverse Events for romosozumab in the Phase 3 ARCH study in osteoporosis suggests a much lower chance of FDA approval for the drug and may "kill" romosozumab's development. He notes that Merck's (MRK) cathepsin-K inhibitor was previously discontinued due to increased risk of atrial fibrillation and stroke. In addition to the safety signals, Newman points out that romosozumab was worse than Radius' (RDUS) Tymlos for non-vertebral fracture and for vertebral fracture, suggesting Radius' drug also has much better efficacy, said the analyst, who keeps a Buy rating and $85 price target on Radius Health shares, which are up $4.47, or 12.8%, to $39.40 in pre-market trading.
06/05/17
PIPR
06/05/17
NO CHANGE
PIPR
Piper views AstraZeneca, J&J as ASCO standouts
The standouts at ASCO over the weekend were the "compelling results" presented on Johnson & Johnson's (JNJ) Zytiga from the Latitude study in prostate cancer and AstraZeneca's (AZN) Lynparza in the OlympiAD trial in BRCA mutant breast cancer, Piper Jaffray analyst Richard Purkiss tells investors in a research note. In lung cancer, Merck's (MRK) updated data in KN021G "appears more promising" than Bristol-Myers' (BMY) updated data in CM012, the analyst adds. Purkiss believes, however, that relative to recent ASCOs, the data "so far in totality is underwhelming."
06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
06/06/17
BMOC
06/06/17
NO CHANGE
BMOC
Incyte should be bought on recent weakness, says BMO Capital
BMO Capital analyst M. Ian Somaiya says that data on the combination of Bristol-Myers' (BMY) Opdivo and Incyte's (INCY) epacadostat "confirmed the benefit" seen in a previous study. The analyst says that the safety of Merck's (MRK) Keytruda in combination with epacadostat is better than the standard of care. He keeps a $166 price target and Outperform rating on Incyte.

TODAY'S FREE FLY STORIES

BABA

Alibaba

$185.13

-0.3 (-0.16%)

18:01
11/19/17
11/19
18:01
11/19/17
18:01
Hot Stocks
Alibaba, Auchan Retail, Ruentex form new retail strategic alliance »

Alibaba, Auchan Retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, CMCSA

Comcast

$36.16

-0.91 (-2.45%)

17:32
11/19/17
11/19
17:32
11/19/17
17:32
Hot Stocks
Box Office Battle: 'Justice League' wins weekend with just $96M »

Warner Bros.' (TWX)…

TWX

Time Warner

$88.72

0.71 (0.81%)

CMCSA

Comcast

$36.16

-0.91 (-2.45%)

CMCSK

Comcast

SNE

Sony

$46.17

0.07 (0.15%)

FOX

21st Century Fox

$30.48

1.88 (6.57%)

FOXA

21st Century Fox

$31.15

1.83 (6.24%)

LGF.A

Lionsgate

$32.59

1.55 (4.99%)

DIS

Disney

$103.44

-0.16 (-0.15%)

VIAB

Viacom

$26.15

2.46 (10.38%)

VIA

Viacom

$33.00

2.9 (9.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

17:10
11/19/17
11/19
17:10
11/19/17
17:10
Periodicals
GE yet to decide which directors will lose seats, WSJ reports »

A housecleaning at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$90.83

-0.66 (-0.72%)

17:01
11/19/17
11/19
17:01
11/19/17
17:01
Hot Stocks
Galapagos NV reports positive topline results from ALBATROSS with GLPG2222 »

Galapagos NV reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$262.26

-1.44 (-0.55%)

16:55
11/19/17
11/19
16:55
11/19/17
16:55
Hot Stocks
Boeing, Avolon finalize deal for 75 737 MAX airplanes »

Boeing and Avolon have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBLK

Star Bulk Carriers

$9.60

0.19 (2.02%)

16:53
11/19/17
11/19
16:53
11/19/17
16:53
Earnings
Star Bulk Carriers reports Q3 adjusted EPS (8c), consensus (5c) »

"We released today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

BDRBF

Bombardier

$2.43

0.0007 (0.03%)

16:22
11/19/17
11/19
16:22
11/19/17
16:22
Hot Stocks
Bombardier predicts Latin America's 60-150 seat aircraft fleet will double »

Bombardier Commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TSLA

Tesla

$315.05

2.55 (0.82%)

10:21
11/18/17
11/18
10:21
11/18/17
10:21
Periodicals
Tesla new super car to cost $200,000, Recode says »

Alongside its new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 16

    Jan

GT

Goodyear Tire

$29.94

0.63 (2.15%)

10:17
11/18/17
11/18
10:17
11/18/17
10:17
Hot Stocks
Goodyear Tire, NASCAR extend relationship »

NASCAR and Goodyear Tire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Jan

  • 16

    Jan

HMC

Honda

$32.62

0.02 (0.06%)

10:05
11/18/17
11/18
10:05
11/18/17
10:05
Periodicals
Honda recalls 900,000 minivans on tip forward seats, Reuters says »

Honda Motor is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.43

-0.82 (-0.92%)

09:48
11/18/17
11/18
09:48
11/18/17
09:48
Periodicals
Activist investors Nelson Peltz still in P&G picture, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

, GE

General Electric

$18.21

-0.04 (-0.22%)

09:39
11/18/17
11/18
09:39
11/18/17
09:39
Periodicals
Buy Baker Hughes, Barron's says »

While it is "not…

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

GE

General Electric

$18.21

-0.04 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CSCO

Cisco

$35.90

0.02 (0.06%)

09:19
11/18/17
11/18
09:19
11/18/17
09:19
Periodicals
More needed for Cisco to have 'groove back,' Barron's says »

While the Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

IBM

IBM

$148.97

-0.15 (-0.10%)

09:10
11/18/17
11/18
09:10
11/18/17
09:10
Periodicals
IBM could be next to fetch higher valuation, Barron's says »

Investors are warming to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GE

General Electric

$18.21

-0.04 (-0.22%)

09:05
11/18/17
11/18
09:05
11/18/17
09:05
Periodicals
Option play offer some help given GE dividend, depressed stock, Barron's says »

While wagering against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

09:00
11/18/17
11/18
09:00
11/18/17
09:00
Periodicals
Risk remains after GE dividend cut, Barron's says »

While buying General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, T

AT&T

$34.51

-0.01 (-0.03%)

08:21
11/18/17
11/18
08:21
11/18/17
08:21
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWX

Time Warner

$88.72

0.71 (0.81%)

T

AT&T

$34.51

-0.01 (-0.03%)

NYT

New York Times

$17.65

0.05 (0.28%)

TEX

Terex

$44.82

0.8 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

TPIC

TPI Composites

$19.06

-0.97 (-4.84%)

07:25
11/18/17
11/18
07:25
11/18/17
07:25
Conference/Events
TPI Composites to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SYNA

Synaptics

$38.21

0.57 (1.51%)

04:55
11/18/17
11/18
04:55
11/18/17
04:55
Conference/Events
Synaptics management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

, MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

17:56
11/17/17
11/17
17:56
11/17/17
17:56
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

17:55
11/17/17
11/17
17:55
11/17/17
17:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UQM

UQM Technologies

$1.18

0.015 (1.29%)

17:24
11/17/17
11/17
17:24
11/17/17
17:24
Syndicate
Breaking Syndicate news story on UQM Technologies »

UQM Technologies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.